Related Experiment Video
Updated: Jan 25, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Activation of Pyroptotic Cell Death Pathways in Cancer: An Alternative Therapeutic Approach
Kanipandian Nagarajan1, Kannan Soundarapandian2, Rick F Thorne3
1Department of Hepato-Biliary Pancreatic Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan Province, People's Republic of China.
Abstract:
Cancer can be considered the result of a series of genetic variations that lead to a normal cell being transformed into a malignant one while avoiding cell death-atypical characteristics of tumor development. Although a large number of genomics and epigenetic alterations have been identified in cells undergoing apoptotic, autophagic or necrotic cell death, the treatment of cancer remains thought-provoking. Pyroptosis is differentiated from other types of programmed cell death and is mainly activated by Caspase-1. To initiate pyroptosis, cells receive specific "death" messages, produce cytokines, swell, burst, and ultimately die. The deficiency of Caspase-1 expression may lead to inflammation-mediated tumor progression. Hence, the molecular mechanisms for the Caspase-1 activation in tumor tissues are yet to be exploited extensively. This review aims to summarise the latest discoveries about pyroptosis and its new exciting role in inducing cancer cell death.
Insights
Pyroptosis, a programmed cell death pathway activated by Caspase-1, offers a novel approach to cancer treatment. Understanding its role in cancer cell death could lead to new therapeutic strategies.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Cancer develops from genetic variations causing uncontrolled cell growth and evasion of cell death.
- While apoptosis, autophagy, and necrosis are known cell death pathways, cancer treatment remains challenging.
- Pyroptosis is a distinct programmed cell death form, primarily triggered by Caspase-1, involving cell swelling and lysis.
Purpose of the Study:
- To review recent advancements in understanding pyroptosis.
- To explore the emerging role of pyroptosis in promoting cancer cell death.
Main Methods:
- Literature review of studies on pyroptosis and cancer.
- Analysis of molecular mechanisms underlying Caspase-1 activation in tumors.
Main Results:
- Pyroptosis is initiated by specific death signals leading to cytokine release, cell swelling, and bursting.
- Caspase-1 deficiency can promote tumor progression through inflammation.
- The precise mechanisms of Caspase-1 activation in tumor tissues require further investigation.
Conclusions:
- Pyroptosis presents a promising avenue for cancer therapy by inducing cancer cell death.
- Further research into pyroptosis mechanisms, particularly Caspase-1 activation in tumors, is crucial for therapeutic development.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

